Transdermal Patch Manufacturing
The production of transdermal patches is a continuous and artisanal process that consists of 3 stages that reflect how delicate and specific is the production of this niche pharmaceutical form. Let´s review it!
5 advantages of transdermal patches over other types of medication delivery system
In this article we share the most important advantages that transdermal patches have over other dosage forms and routes of administration.
Drug-In Adhesive (DIA) patches, a simple design surrounded of demanding challenges
Far away, in 1979, the first transdermal patch to reach the market, produced under an industrial controlled process and backed by clinical studies, was launched in US under the brand name TransderScop®.
Assessment of the requirements for the submission of generic transdermal systems in Latin America
The Latin American surveillance health authorities have made progress year after year with respect to the requirements of product registration in general, seeking the best balance between the safety of its inhabitants, the efficacy of the products and the economic reality of each country.
Transdermal Drug Delivery Systems and 505(b)(2) / Hybrid Regulatory Pathways.
Transdermal drug delivery systems, also named as “patches”, are controlled release dosage forms designed to deliver a therapeutically effective amount of drug through the skin during the time of application of the product, which may vary between 9 h (methylphenidate) to 148 h (buprenorphine).